- Home
- BMA
as 07-26-2024 4:00pm EST
Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.
| Founded: | N/A | Country: | Argentina |
| Employees: | N/A | City: | N/A |
| Market Cap: | 3.4B | IPO Year: | 2006 |
| Target Price: | N/A | AVG Volume (30 days): | 218.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | 9.88 | EPS Growth: | 362.64 |
| 52 Week Low/High: | $17.30 - $68.24 | Next Earning Date: | 08-06-2024 |
| Revenue: | $3,519,599,964 | Revenue Growth: | 84.53% |
| Revenue Growth (this year): | 23.11% | Revenue Growth (next year): | 10.48% |
Latest Banco Macro S.A. ADR (representing Ten Class B) News
BMA Breaking Stock News: Dive into BMA Ticker-Specific Updates for Smart Investing
Zacks
14 days ago
Is Macro Bank (BMA) Stock Outpacing Its Finance Peers This Year?
Zacks
a month ago
Itau Unibanco (ITUB) Rides on Strategic Buyouts Amid High Costs
Zacks
a month ago
Is DBS Group (DBSDY) Outperforming Other Finance Stocks This Year?
Zacks
a month ago
3 Top Dividend Stocks to Maximize Your Retirement Income
Zacks
a month ago
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
Zacks
2 months ago
Is American Express (AXP) Outperforming Other Finance Stocks This Year?
The Telegraph
2 months ago
Italian energy company targets Britain for fleet of 20 mini-nukes
Motley Fool
2 months ago
4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
Compare BMA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BMA Banco Macro S.A. ADR (representing Ten Class B) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.